Hygea VCT plcInterested in
trading this stock?
Hygea VCT provides investors with access to a diversified portfolio of emerging and established MedTech companies qualifying for investments by a VCT. The board has a strong track record of investing in this area and has a network of personnel with successful P & L responsibility experience in the MedTech sector, both in the UK and internationally. A key feature of the Hygea investment approach is to ensure that portfolio companies are developed as solutions companies i.e. compete on the basis of value provided to customers (not price) by providing better patient outcomes at lower total cost. The effect of this approach is that portfolio companies tend to be focused around medical devices, drug delivery systems, diagnostics and technology based support services - standalone molecule development companies do not generally qualify as solutions companies.
No auction history
|Next auction date||Indicative price||Highest bid (p)||Lowest offer (p)||Market type||Auction frequency||Next auction time|
|30 May 13||n/a||n/a||n/a||Open||Monthly||5:00pm|
|Result of AGM ansd Interim Management Statement||09 May 13|
|Share Trading – End of Close Period||22 Mar 13|
|Close Period||02 Jan 13|
Report & accounts
|Report and Accounts to December 2012||22 Mar 13|
|Interim Accounts to June 12||30 Aug 12|
|Report and Accounts to December 2011||22 Mar 12|
|Year ending||Sales (£m)||Pre-tax profit (£m)|
|31 Dec 2011||N/A||-0.1430|
|James Otter (Chairman)|